Respirology

Article	Citations
	163
Reassessing pyrazinamide: Disentangling the myth of dose‐dependent hepatotoxicity and advancing dosing strategies in elderly tuberculosis patients	88
Response to “Fixed CPAP at 10 cmH2O for OSA: A One‐Size‐Fits‐All Approach?”	69
Influence of Staphylococcal enterotoxin‐specific IgE sensitization on therapeutic efficacy of omalizumab therapy in severe asthma	67
Issue Information	66
Broadening Our Understanding of Genetic Risk to Interstitial Lung Disease in Understudied Populations	63
World Lung Day 2025—Healthy Lungs, Healthy Life	59
Language concordance in healthcare: Beyond just talk	54
Limitations of Self‐Reported Data in Evaluating COPD Phenotypes and Cardiovascular Risk	54
Effectiveness of Perioperative Radiotherapy With Systemic Therapy on Survival of Squamous Cell Lung Cancer Patients With Pathologic N2	54
Omics technologies to study virus infection and chronic lung diseases	52
APSR 2024 Abstracts	45
The Brompton Breathing Pattern Assessment Tool ( BPAT ): A Journey to Identify the Unknown, a Decade on…	43
Prenatal PM 2 .5 Exposure and Airway Mech	42
Effectiveness of Active Video Games as a Training Tool in Patients With Interstitial Lung Disease: A Randomised Controlled Trial	41
The Assessment of Subglottic and Cervical Tracheal Stenosis Using a Novel Point‐of‐Care Ultrasound Method: Measurement of Tracheal Radius Curvature	41
Real‐World Evaluation of a Rapid Multiplex PCR Panel in Adults Hospitalized With COPD Exacerbation	38
Trends of global and regional aetiologies, risk factors and mortality of lower respiratory infections from 1990 to 2019: An analysis for the Global Burden of Disease Study 2019	37
Asthma and landscape fire smoke: A Thoracic Society of Australia and New Zealand position statement	37
Bayesian adaptive clinical trial designs for respiratory medicine	34
Prevention of droplet dispersal with ‘e‐mask’: A new daily use endoscopic mask during bronchoscopy	34
Issue Information	33
Predicting Failure: Can Blood Biomarkers Identify Likely Treatment Non‐Responders in IPF?	32
	32
Enhancing COPD Care for Women: A Predictive Tool for Palliative Needs	31

The chicken or the egg: Sleep or physical activity?	31
Predicting Failure at Initiation of High‐Flow Nasal Oxygen in Patients With COVID ‐19: Literature Review, Development and Internal Validation of a Pr	30
Singing in and out of COVID	30
Maximising Participation in the Australian National Lung Cancer Screening Program: A Discrete Choice Experiment of Eligible, High‐Risk Individuals	30
A New Opportunity in Respirology	29
Adding some NOVELTY to treatable traits	29
From light to sound: Ultrasound outshines Light's criteria for pleural effusions classification	28
Issue Information	28
Safety and efficacy of bronchial thermoplasty in Australia 5 years post‐procedure	27
Letter From The Philippines—Breathing Life Into the Nation: The Philippine College of Chest Physicians and Its Impact on Respiratory Health	27
Smoking, respiratory symptoms, lung function and life expectancy: A longitudinal study of ageing	25
Transplantation of Ex Vivo Amplified Mononuclear Cells From Peripheral Blood Improves Rat Pulmonary Hypertension via CD14 ‐ and <	25
Antifibrotics and lung transplantation: A Spanish multicentre case‐controlled study	24
Obesity is a major contributing cause of breathlessness in the population	23
Effect of antifibrotic agents on postoperative complications after lung transplantation for idiopathic pulmonary fibrosis	23
Associations of early life and childhood risk factors with obstructive sleep apnoea in middle‐age	23
Proposed quality indicators and recommended standard reporting items in performance of EBUS bronchoscopy: An official World Association for Bronchology and Interventional Pulmonology E	22
Effects of Air Pollution Exposure and the MUC5B rs35705950 Variant on Interstitial Lung Disease Risk in Patients With Rheumatoid Arthritis	22
Allele‐specific micro‐RNA‐mediated regulation of ADAM33 in childhood allergic asthma	22
Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis	22
Letter from Canada: Global warming and wildfire smoke pollution emerging as major threats to respiratory health	22
	21
Transitional Lung Function Paths in Young Adults: More Opportunities for Prevention?	21
Abstract	20
Issue Information	20
My Lungs Have Feelings Too!	20
Issue Information	20
Pneumothorax in Endobronchial Valve Therapy–Still a Lot to Be Learned	20
Issue Information	19
	19
Correction to “Predictive role of neutrophil‐percentage‐to‐albumin, neutrophil‐to‐lymphocyte and eosinophil‐to‐lymphocyte ratios for mortality in patients with COPD	19
An additional mechanism enhancing exercise tolerance in interstitial lung disease with high‐flow nasal cannula	18
Thoracic Society of Australia and New Zealand (TSANZ) Is Abrogating Its Leadership Role in Asia‐Pacific	18
Letter from Australia	18
Conspiracy Theories, MDTs and Communication	18
Uncontrolled mild‐to‐moderate asthma may not be mild or moderate, or even asthma: The benefits of early phenotyping	18
Issue Information	18
Sleep medicine is more than just obstructive sleep apnoea	17
Promotion of physical activity after hospitalization for COPD exacerbation: Aids and barriers	17
The 63rd Annual Meeting of the Japanese Respiratory Society	16
Erythromycin Shortage in an NTM ‐Endemic Country: Implications for Bronchiectasis Care and Antimicrobial Stewardship	16
Severe asthma, more than that?	16
A snorkel mask with a 3D‐printed adaptor to HEPA filter was used in a COVID‐19 emergency ward to provide safe respiratory support	16
The Olympics have arrived: The challenge of exercise‐induced bronchoconstriction in athletes	16
A New Era in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis	15
Corrigendum	15
Chest x‐ray has low sensitivity to detect silicosis in artificial stone benchtop industry workers	15
Letter from Vietnam	15
Add‐On Dextromethorphan Improves the Effects of Pirfenidone in Bleomycin‐Treated Mice and Patients With Pulmonary Fibrosis	15
Letter from the United States: An update on the New York experience with COVID‐19	14

	14
Author Index	14
Leading Women in Respiratory Clinical Sciences: Letter From Japan	14
Issue Information	14
A Comprehensive Review of Interstitial Lung Abnormalities	14
	14
	13
The United Nations Framework Convention on Climate Change (UNFCCC) 28th Conference of the Parties, Dubai (COP28): Implications for lung disease	13
Hansen's disease and the first patient disease Registry	13
High Flow Nasal Oxygen and Low Flow Oxygen Are Equally Effective in Providing Oxygenation During Bronchoscopy Under Conscious Sedation: A Randomised Controlled Trial	13
Correction to APSR Annual Conference ‐ 28th Congress of the Asian Pacific Society of Respirology, 7–10 November 2024, Hong Kong.	13
Transformative radiology: Chest imaging is being re‐defined	13
Validation of the clinical utility of sGaw as a response variable in methacholine challenge testing	13
	13
Association of short‐term exposure to PM1 with hospital admission from total and cause‐specific respiratory diseases	12
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe	12
Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study	12
Innovations in thoracic imaging: CT, radiomics, AI and x‐ray velocimetry	12
Feasibility of a Modified Bronchoscopic Transparenchymal Nodule Access Technique (‘Essen Tunnel’) for Improving the Diagnosis of Intraparenchymal Pulmonary Lesions	12
Determinants of radiation exposure during mobile cone‐beam CT‐guided robotic‐assisted bronchoscopy	12
Issue Information	11
Issue Information	11
Global, regional and national burden of chronic obstructive pulmonary disease over a 30‐year period: Estimates from the 1990 to 2019 Global Burden of Disease Study	11
Presence of anti‐modified protein antibodies in idiopathic pulmonary fibrosis	11
Prognostic Value of a Cardiopulmonary Exercise Testing‐Derived Summed Score in Idiopathic Pulmonary Fibrosis and Connective Tissue Disease‐Associated Interstitial Lung Disease: A Prospective Cohort St	11
	11
Illness, chocolate and Harry Potter	10
Letter from Iceland	10
A visit to the gallery	10
NT ‐ proBNP and BNP Testing in Pulmonary Arterial Hypertension: Poi	10
Current evidence on supranormal lung function: A call for longitudinal research to optimize lung health	10
Correction to “ APSR Annual Conference ‐ 28th Congress of the Asian Pacific Society of Respirology, 7–10 November 2024, Hong Kong.	10
Breath‐holding physiology, radiological severity and adverse outcomes in COVID‐19 patients: A prospective validation study	10
Adaptation in real time: Wildfire smoke exposure and respiratory health	10
	10
Patients' and Health Professionals' Views on Using Oral Corticosteroids for Asthma: Priorities, Trade‐Offs and Shared Decision‐Making	10
Robotic One Anaesthetic Marking And Resection ( ROMAR ): A Novel Approach for Thoracoscopic Sublobar Resection of Peripheral Pulmonary Lesions	9
Tackling a Lifetime of Risk for OSA	9
The Association Between Use of Inhaled Corticosteroids and Long‐Acting Beta2‐Agonists During Pregnancy and Adverse Fetal Outcomes	9
Contemporary Concise Review 2023: Interstitial lung disease	9
A Mechanistic and Morphologic Approach to Managing Benign Central Airway Obstruction	9
Small Airways and Pulmonary Diffusing Capacity Decline in an 8‐Year Longitudinal Population Study	9
A Novel Method Using Dual‐Energy Computed Tomography for Detecting Amiodarone‐Induced Lung Injury: A Cohort Pilot Study	9
Ηeparan sulphate in infectious and non‐infectious exacerbations of COPD	9
Issue Information	9
Letter From the Sri Lanka College of Pulmonologists	9
Smoking: Quit to win	8
Letter from the Czech Republic	8
Development and Validation of a Clinical Scoring System Predicting 30‐Day Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis	8
Effect of an artificial intelligence tool on management decisions for indeterminate pulmonary nodules	8
Extracellular traps are evident in Romanowsky‐stained smears of bronchoalveolar lavage from children with non‐cystic fibrosis bronchiectasis	8
Reply to: ‘Is continuous positive airway pressure truly superior to high‐flow nasal cannula in managing acute hypoxemic respiratory failure?’	8
Early Intervention With Biologics for Asthma Remission: Promising or Premature?	8
Cough suppression as a radical but effective therapeutic strategy	8
Consumer engagement—Beyond the usual approaches	8
Looking Towards More Comprehensive Management of Interstitial Lung Disease	8
The Oxygenation Benefits Provided by High‐Flow Nasal Oxygen in Bronchoscopy May Be Underestimated	8
COPD‐related incidence, mortality, and disability: An illustrative summary of the GBD study (1990–2019)	8
Safety and efficacy of a novel transbronchial radiofrequency ablation system for lung tumours: One year follow‐up from the first multi‐centre large‐scale clinical trial ( BRON	8
Thoracic Society of Australia and New Zealand position statement: The safe clinical use of sputum induction for bio‐sampling of the lower airways in children and adults	8
Beyond Single Cytokines: Targeting Co‐Receptor CD131 in Asthma‐COPD Overlap	8
Siloed thinking is limiting health care delivery	8
Urban living	8
Plastics in Every Breath: The Silent Respiratory Health Threat We Cannot Avoid	8
Recommendations from The Medical Education Editor	8
Elevated blood lactate in COPD exacerbations associates with adverse clinical outcomes and signals excessive treatment with β2‐agonists	8
World Association for Bronchology and Interventional Pulmonology (WABIP) guidelines on airway stenting for malignant central airway obstruction	7
Increased exacerbations of bronchiectasis following recovery from mild COVID‐19 in patients with non‐cystic fibrosis bronchiectasis	7
Breathlessness: Remembering the worst of it	7
Small babies at birth, small lungs for life?	7
Inflammation‐induced loss of CFTR ‐expressing airway ionocytes in non‐eosinophilic asthma	7
The Western Australian Mesothelioma Registry: Analysis of 60 years of cases	7
Addressing the Global Challenges of COPD and Asthma: A Shared Vision From the Global Initiative for Chronic Obstructive Pulmonary Disease (	7
	7
World Lung Day 2023—Access to prevention and treatment for all, leave no one behind	7
Right Atrial Pressure/Pulmonary Artery Wedge Pressure Ratio Correlates With Early Outcomes After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension	7
The treatable traits approach to adults with obstructive airways disease in primary and secondary care	7
Contemporary Concise Review 2023: Environmental and occupational lung diseases	7
Understanding Nontuberculous Mycobacterial Pulmonary Disease as a Chronic Lung Disease	7
Home sweet home… or is it?	7

Issue Information	6
Letter from Belgium	6
Breaking the spiral: How negative mood can fuel exertional breathlessness in people with chronic obstructive pulmonary disease	6
Upadacitinib Versus Tofacitinib in Anti‐ MDA5 ‐Positive Dermatomyositis With Interstitial Lung Disease: A Multi‐Centre Cohort Study Emulating a Targe	6
Objective Effects and Patient Preferences for Ambulatory Oxygen in Fibrotic Interstitial Lung Disease With Isolated Exertional Hypoxaemia: A Placebo‐Controlled 6‐Minute Walk Test Study	6
Atomoxetine and fesoterodine combination improves obstructive sleep apnoea severity in patients with milder upper airway collapsibility	6
Long‐term trends of COPD mortality: Gaps and opportunities	6
The Case for Case Finding Is Getting Stronger	6
Quantitative computed tomography of the chest for fibrotic lung diseases: Prime time for its use in routine clinical practice?	6
Leading women in respiratory clinical sciences: Letter from Australia	6
Cardiovascular Effect of Snoring in Asians: What Do Biobank and Genomic Studies Say?	6
Pre‐transplant anti‐fibrotics for idiopathic pulmonary fibrosis: Are we seeing a new role for the anti‐fibrotics?	6
Correction to “Feasibility of a Modified Bronchoscopic Transparenchymal Nodule Access Technique (‘Essen Tunnel’) for Improving the Diagnosis of Intraparenchymal Pulmonary Lesions”	6
Issue Information	6
	6
Clinical and Inflammatory Phenotypes During Exacerbations Predict In‐Hospital Adverse Outcomes in Asthma‐ COPD Overlap	6
Preliminary Development of a Patient‐Reported Outcome Measure for Inducible Laryngeal Obstruction: Findings From a Delphi Process	6
Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial	6
Nintedanib in Asian patients with progressive fibrosing interstitial lung diseases: Results from the INBUILD trial	6
Issue Information	6
Letter from South Africa	6
Letter from the UK: Reflections on a turbulent 5 years	6
Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statement	6
Pathological Examination and Genetic Mutation Testing: Bridging Their Best Practices Using MINtS	6
Racial and ethnic disparities in antifibrotic therapy in idiopathic pulmonary fibrosis	6
Reliability of Rapid On‐Site Evaluation Achieved by Remote Sharing Systems (E‐ ROSE ) and AI Algor	6
Into the meaning of Respirology, Pulmonology and Pneumology	6
Stirring the publishing pot by ending accept/reject decisions	6
	5
Covid‐19 pandemic and asthma: What did we learn?	5
Clinical trials and clinical trials networks	5
Contemporary Concise Review 2024: Respiratory Infections	5
	5
Optimal clinical practice in IPF and PPF: Integrating the scientific ethos and clinical reasoning	5
Benefits of chest wall mobilization on respiratory efficiency and functional exercise capacity in people with severe chronic obstructive pulmonary disease (COPD): A randomized controlled tr	5
Letter From the Vietnam Respiratory Society—Vietnam's Respiratory Medicine in Transition: From Clinical Advances to National Healthcare Policy	5
Safety of pyrazinamide in elderly patients with tuberculosis in Japan: A nationwide cohort study	5
Effect of pulmonary rehabilitation duration on exercise capacity and health‐related quality of life in people with chronic obstructive pulmonary disease	5
A paediatric bronchoscopist's ‘Field of Dreams’: Will the flexible cryoprobe hit a home run?	5
	5
Quantum Respiratory Science	5
Leading women in Respiratory Medicine: Letter from the ERS	5
A snapshot of SABA co‐prescribing with ICS‐formoterol maintenance and reliever therapy	5
Vaccination in patients with COPD: COVID has raised the bar	5
Checkpoint inhibitors are a basic science‐based, transformative new treatment for lung cancer	5
Overexpression of SMAD7 improves the function of EGFR‐targeted human CAR‐T cells against non‐small‐cell lung cancer	5
Association of Airway Mucus Plugs and Physical Activity, Exercise Tolerance, Sarcopenia, and Frailty in Patients With COPD and Pre‐	5
Author Index	5
Risk of childhood asthma in those born small	5
Molecular Investigation in Early‐Onset Interstitial Lung Disease: Results From 699 Unrelated Patients	5
What Matters for Prediction? Leukocyte Count and Risk Stratification in Pulmonary Embolism	5
Lifetime Body Mass Index Trajectories and Contrasting Lung Function Abnormalities in Mid‐Adulthood: Data From the Tasmanian Longitudinal Health Study	4
TSANZ Abstracts	4
How does one get around many of the confounding factors influencing the response to methacholine?	4
Clinical Presentation and Diagnostic Evaluation of Vaping Related Lung Injury in Youth	4
Recommendations From the Medical Education Editor	4
Issue Information	4
Obstructive Sleep Apnoea Treatments—Where Are We Now?	4
CD131 antagonism blocks inflammation, emphysema and fibrosis in an asthma‐COPD overlap mouse model originating in early life	4
Auto‐adjusted versus fixed positive airway pressure in patients with severe OSA: A large randomized controlled trial	4
Evaluating artificial intelligence responses to respiratory medicine questions	4
Aetiology of Adult Community‐Acquired Lung Abscess in Hong Kong	4
Issue Information	4
Heated Tobacco Product Use and Lower Physical Activity Among Japanese Adults With and Without Respiratory Diseases: Findings From the JACSIS Study	4
Non‐Intubated VATS for Interstitial Lung Disease Diagnosis: A Safer Technique or Too Soon to Tell?	4
Effects of early mobilization on patients with COVID‐19 with respiratory failure	4
Issue Information	4
Response to ‘Reassessing pyrazinamide: Disentangling the myth of dose‐dependent hepatotoxicity and advancing dosing strategies in elderly tuberculosis patients’	4
Pre‐Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients	4
Benralizumab and mepolizumab treatment outcomes in two severe asthma clinics	4
Small for gestational age is associated with reduced lung function in middle age: A prospective study from first to fifth decade of life	4
PMN‐MDSCs Orchestrate the Immunosuppressive Microenvironment in the Lung and Are Associated With Clinical Outcome in Bronchiectasis	4
Food for the Lungs: The Mediterranean Diet and Adult‐Onset Asthma	4
Diffusion capacity and static hyperinflation as markers of disease progression predict 3‐year mortality in COPD: Results from COSYCONET	4
Virtual bronchoscopic navigation and endobronchial ultrasound with a guide sheath without fluoroscopy for diagnosing peripheral pulmonary lesions with a bronchus leading to or adjacent to the lesion:	4
Fixed Pressure Wins Again: Why Obesity Hypoventilation Syndrome Demands Stability	4
PDE5 to keep them alive: The use of phosphodiesterase type‐5 inhibitors in severe pulmonary hypertension associated with interstitial lung disease	4
From Residency to Tissue Inflammatory Memory: HLF as a Transcriptional Gatekeeper of CD4 +	4
Issue Information	4
Rheumatoid factor and anti‐citrullinated antibodies in non‐connective tissue interstitial lung disease: The chicken or the egg?	4
Hypoxic indices for obstructive sleep apnoea severity and cardiovascular disease risk prediction: A comparison and application in a community population	4
Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics	4
Reply to “Familial Segregation Highlights Challenges in Rare SFTPA2 Variant Classification”	4
Endotyping in sleep surgery: Not ready for primetime	4
Inter‐Night Variability of Nocturnal Pulse Oximetry in People Living With Motor Neuron Disease: A Retrospective Observational Study	4
Which biologic? New findings from a real‐world study	4
Sputum Metagenomics Reveals Multidrug‐Resistant Pseudomonas‐Dominant Communities in Severe Asthma	4
Familial Segregation Highlights Challenges in Rare SFTPA2 Variant Classification	4
Bronchiectasis: A pulmonary disease with systemic consequences	4